Nebraska Hematology Oncology’s Breast Cancer Research Findings Published

The physicians and staff at Nebraska Hematology Oncology P.C. (www.yourcancercare.com)are pleased to announce that their breast cancer research findings have been published in the October issue of Anticancer Research. The research evaluates how accurately the techniques of physical examination and imaging predict an individual’s tumor response to neoadjuvant chemotherapy, with primary consideration of the individual’s specific breast cancer subtype.

Waldrep A, Avery E, Rose F, Midathada M, Tilford J, Kolberg HC, Hutchins M. Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy. Anticancer Res. 2016; 36(10):5389-5395. http://ar.iiarjournals.org/content/36/10/5389.abstract.

It is the hope of the professionals at Nebraska Hematology Oncology P.C. that these hypothesis-generating findings will inspire additional prospective research that could confirm which methods of clinical evaluation provide the most accuracy and value for each breast cancer patient receiving neoadjuvant chemotherapy.

At Nebraska Hematology Oncology P.C., their mission is to guide and support patients and their families through the challenges of cancer and blood disorders. All doctors, nurses, and staff focus on providing comprehensive, compassionate care. Nebraska Hematology Oncology P.C. is located at 4004 Pioneer Woods Dr. in Lincoln. For more information, please call (402) 484-4900, toll-free at (877) 436-3662, or visit www.yourcancercare.com.